These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37459718)

  • 1. Identifying risk factors for adverse events of pyridoxal phosphate in infantile epileptic spasms syndrome.
    Arai Y; Okanishi T; Kanai S; Ohta K; Sunada H; Noma H; Maegaki Y
    Epilepsy Behav; 2023 Aug; 145():109348. PubMed ID: 37459718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional vitamin B12 deficiency-associated Infantile epileptic spasms syndrome: Clinico-neurophysiological presentation, response to treatment, and neurodevelopmental outcome.
    Sharawat IK; Ramachandran A; Elwadhi A; Tomar A; Panda PK
    Seizure; 2023 Aug; 110():93-98. PubMed ID: 37331199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term analysis of adrenocorticotropic hormone monotherapy for infantile epileptic spasms syndrome with periventricular leukomalacia.
    Matsuura R; Hamano SI; Hirata Y; Takeda R; Takeuchi H; Koichihara R; Kikuchi K; Oka A
    Seizure; 2023 Jul; 109():40-44. PubMed ID: 37207538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome.
    Kuchenbuch M; Lo Barco T; Chemaly N; Chiron C; Nabbout R
    Epilepsia; 2024 Feb; 65(2):430-444. PubMed ID: 37872396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cohort study of infantile epileptic spasms syndrome: etiological analysis and treatment of corticosteroids.
    Jiang Y; Zou N; Luo Y; Cheng M; Liao S; Hong S; Liang X; Zhong M; Li T; Jiang L
    Seizure; 2022 Oct; 101():120-126. PubMed ID: 35952490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landscape of genetic infantile epileptic spasms syndrome-A multicenter cohort of 124 children from India.
    Nagarajan B; Gowda VK; Yoganathan S; Sharawat IK; Srivastava K; Vora N; Badheka R; Danda S; Kalane U; Kaur A; Madaan P; Mehta S; Negi S; Panda PK; Rajadhyaksha S; Saini AG; Saini L; Shah S; Srinivasan VM; Suthar R; Thomas M; Vyas S; Sankhyan N; Sahu JK
    Epilepsia Open; 2023 Dec; 8(4):1383-1404. PubMed ID: 37583270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified cannabidiol as add-on therapy in children with treatment-resistant infantile epileptic spasms syndrome.
    Reyes Valenzuela G; Gallo A; Calvo A; Chacón S; Fasulo L; Galicchio S; Adi J; Fortini PS; Caraballo R
    Seizure; 2024 Feb; 115():94-99. PubMed ID: 38237316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing the clinical onset of epileptic spasms in infantile epileptic spasms syndrome: A tertiary health center's experience.
    Hadjinicolaou A; Briscoe Abath C; Singh A; Donatelli S; Salussolia CL; Cohen AL; He J; Gupta N; Merchant S; Zhang B; Olson H; Yuskaitis CJ; Libenson MH; Harini C
    Epilepsia; 2024 Apr; 65(4):984-994. PubMed ID: 38317356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of infantile epileptic spasms syndrome: What have we learned from animal models?
    Ng AC; Choudhary A; Barrett KT; Gavrilovici C; Scantlebury MH
    Epilepsia; 2024 Feb; 65(2):266-280. PubMed ID: 38036453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction model for long-term seizure and developmental outcomes among children with infantile epileptic spasms syndrome.
    Arai Y; Okanishi T; Kanai S; Nakamura Y; Sunada H; Murakami H; Yamauchi K; Noma H; Maegaki Y
    Front Neurol; 2023; 14():1195252. PubMed ID: 37521298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype.
    Kenney-Jung DL; Rogers DJ; Kroening SJ; Zatkalik AL; Whitmarsh AE; Roberts AE; Zenker M; Gambardella ML; Contaldo I; Leoni C; Onesimo R; Zampino G; Tartaglia M; Battaglia DI; Pierpont EI
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):501-509. PubMed ID: 36448195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials.
    Osborne JP; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FK
    Eur J Paediatr Neurol; 2023 Jan; 42():110-116. PubMed ID: 36621063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early transient dysautonomia predicts the risk of infantile epileptic spasm syndrome onset: A prospective cohort study.
    Goswami I; Maguire B; Chau V; Tam EW; Pinchefsky E; Whitney R; Wilson D; Miller SP; Cortez MA
    Front Neurol; 2022; 13():1090155. PubMed ID: 36619920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Advancements in Infantile Epileptic Spasms Syndrome and Opportunities for Precision Medicine.
    Snyder HE; Jain P; RamachandranNair R; Jones KC; Whitney R
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of infantile spasms with high-dose pyridoxal phosphate and low-dose corticotropin.
    Takuma Y; Seki T
    J Child Neurol; 1996 Jan; 11(1):35-40. PubMed ID: 8745383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta-analysis.
    Xu Z; Gong P; Jiao X; Niu Y; Wu Y; Zhang Y; Chang X; Yang Z
    Epilepsia Open; 2023 Jun; 8(2):268-277. PubMed ID: 36740237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors influencing the efficacy of initial adrenocorticotropic hormone therapy for infantile epileptic spasms syndrome].
    Huang X; Peng J; Pan Z; Peng P; He F; Zhang CL; Chen C; Liu FY; Yin F; Mao LL
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jan; 25(1):60-66. PubMed ID: 36655665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy.
    Wang HS; Kuo MF; Chou ML; Hung PC; Lin KL; Hsieh MY; Chang MY
    Arch Dis Child; 2005 May; 90(5):512-5. PubMed ID: 15851435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of pyridoxal in West syndrome: A retrospective study.
    Matsuura R; Hamano SI; Kubota J; Daida A; Ikemoto S; Hirata Y; Koichihara R
    Brain Dev; 2019 May; 41(5):413-419. PubMed ID: 30528382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative pretreatment EEG predicts efficacy of ACTH therapy in infantile epileptic spasms syndrome.
    Kanai S; Oguri M; Okanishi T; Miyamoto Y; Maeda M; Yazaki K; Matsuura R; Tozawa T; Sakuma S; Chiyonobu T; Hamano SI; Maegaki Y
    Clin Neurophysiol; 2022 Dec; 144():83-90. PubMed ID: 36327598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.